fluorescein-5-isothiocyanate has been researched along with Mesothelioma in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gonzalez, M; Krueger, T; Le Bitoux, MA; Perentes, JY; Ris, HB; Vandenbergh, H; Wagnieres, G; Wang, X; Wang, Y | 1 |
Debefve, E; Gonzalez, M; Krueger, T; Lehr, HA; Perentes, JY; Schäfer, SC; van den Bergh, H; Wang, Y | 1 |
Mukthar, D; Schenker, T; Schumacher, U | 1 |
3 other study(ies) available for fluorescein-5-isothiocyanate and Mesothelioma
Article | Year |
---|---|
Fluence plays a critical role on the subsequent distribution of chemotherapy and tumor growth delay in murine mesothelioma xenografts pre-treated by photodynamic therapy.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cisplatin; Dextrans; Fluorescein-5-isothiocyanate; Fluorescent Dyes; Humans; Mesothelioma; Mice, Nude; Microscopy; Neoadjuvant Therapy; Photochemotherapy; Photosensitizing Agents; Porphyrins; Verteporfin; Xenograft Model Antitumor Assays | 2015 |
Photodynamic drug delivery enhancement in tumours does not depend on leukocyte-endothelial interaction in a human mesothelioma xenograft model.
Topics: Animals; Dextrans; Endothelial Cells; Endothelium, Vascular; Fluorescein-5-isothiocyanate; Humans; Leukocytes; Mesothelioma; Mice; Mice, Nude; Neoplasm Transplantation; Photosensitizing Agents; Pleural Neoplasms; Porphyrins; Verteporfin | 2012 |
Reactivity of monoclonal antibodies directed against lung cancer antigens with human lung, breast and colon cancer cell lines.
Topics: Adenocarcinoma; Antibodies, Monoclonal; Antibody Specificity; Antigens, Neoplasm; Biomarkers, Tumor; Breast Neoplasms; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Colonic Neoplasms; Fluorescein-5-isothiocyanate; Fluorescent Antibody Technique; Fluorescent Dyes; Humans; Lung Neoplasms; Mesothelioma; Tumor Cells, Cultured | 1993 |